WITHDRAWN

Accessing Mobility Using Wearable Sensors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will examine whether wearable sensors can be used to track changes in cognitive-motor performance in response to a disease or an intervention. The investigators specific aims are twofold, first aim to explore whether and how a clinical condition such as Chronic obstructive pulmonary disease (COPD) or Congestive Heart Failure (CHF) may impact motor-cognitive performance measurable using validated wearable devices (e.g., LEGSys, BalanSENS, and Frailty Meter). Second, the investigators will explore whether an exercise intervention provided via tele-medicine (tele-rehabilitation) can enhance motor-cognitive performance.

Official Title

Accessing Mobility Quality Using Wearable Sensors

Quick Facts

Study Start:2018-05-21
Study Completion:2025-12-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:WITHDRAWN

Study ID

NCT04306588

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Any individual 18 years old or 65+ older is eligible to participate.
  2. * Must be diagnosed with a chronic illness such as COPD or CHF.
  3. * Should be refereed to one of the tele-rehabilitation program offered at VA-Houston.
  1. * Non-ambulatory (unable to walk with or without assistance a distance of at least 10 meter).
  2. * Unlikely to fully comply with the protocol (e.g., long-distance travel if multiple follow-up visits are required)
  3. * Unwilling to provide informed consent.
  4. * Severe visual and hearing problems who may not be able to interact with tele-rehabilitation.
  5. * Unstable medical region (those who may change medication over next 12 weeks).
  6. * Severe cognitive impairment and psychiatric problems who may not be able to follow tele-rehabilitation instructions based on judgement of clinical investigators.
  7. * Participating in another active intervention that may affect cognitive-motor performance, and those who do not have capacity to consent.

Contacts and Locations

Principal Investigator

Bijan Najafi, PhD
PRINCIPAL_INVESTIGATOR
Baylor College of Medicine

Study Locations (Sites)

Michael E. DeBakey Veterans Affairs Medical Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: Baylor College of Medicine

  • Bijan Najafi, PhD, PRINCIPAL_INVESTIGATOR, Baylor College of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-05-21
Study Completion Date2025-12-30

Study Record Updates

Study Start Date2018-05-21
Study Completion Date2025-12-30

Terms related to this study

Keywords Provided by Researchers

  • COPD
  • CHF
  • Cardiovascular Diseases

Additional Relevant MeSH Terms

  • COPD
  • Pulmonary Disease
  • Pulmonary Restrictive Disease
  • Congestive Heart Failure
  • Cardiovascular Diseases